The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
Abstract
Macrophagic myofasciitis (MMF) is an emerging condition of unknown cause, detected in patients with diffuse arthromyalgias and fatigue, and characterized by muscle infiltration by granular periodic acid-Schiff's reagent-positive macrophages and lymphocytes. Intracytoplasmic inclusions have been observed in macrophages of some patients. To assess their significance, electron microscopy was performed in 40 consecutive cases and chemical analysis was done by microanalysis and atomic absorption spectrometry. Inclusions were constantly detected and corresponded to aluminium hydroxide, an immunostimulatory compound frequently used as a vaccine adjuvant. A lymphocytic component was constantly observed in MMF lesions. Serological tests were compatible with exposure to aluminium hydroxide-containing vaccines. History analysis revealed that 50 out of 50 patients had received vaccines against hepatitis B virus (86%), hepatitis A virus (19%) or tetanus toxoid (58%), 3-96 months (median 36 months) before biopsy. Diffuse myalgias were more frequent in patients with than without an MMF lesion at deltoid muscle biopsy (P < 0.0001). Myalgia onset was subsequent to the vaccination (median 11 months) in 94% of patients. MMF lesion was experimentally reproduced in rats. We conclude that the MMF lesion is secondary to intramuscular injection of aluminium hydroxide-containing vaccines, shows both long-term persistence of aluminium hydroxide and an ongoing local immune reaction, and is detected in patients with systemic symptoms which appeared subsequently to vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis, Dermatomyositis, and Inclusion Body Myositis
Holton, J., Wedderburn, L. R., & Hanna, M. G. (2013) · UCL Discovery (University College London) · Cited by 764
Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia
Sluka, K. A., Kalra, A., & Moore, S. A. (2001) · Muscle & Nerve · doi:10.1002/1097-4598(200101)24:1<37::aid-mus4>3.0.co;2-8 · Cited by 503
Vaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Brewer, J. M., Conacher, M., Hunter, C. A., Mohrs, M., Brombacher, F., & Alexander, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6448 · Cited by 440
Report of four cases and review of the literature
Axton, A. W. L., & Perrin, R. G. (2006) · Cited by 430
Immunological notes. XVII–XXIV
Glenny, A. T., Pope, C. G., Waddington, H., & Wallace, U. (1926) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700290106 · Cited by 399
Chronic fatigue syndrome: clinical condition associated with immune activation
Landay, A. L., Lennette, E. T., Jessop, C., & Levy, J. A. (1991) · The Lancet · doi:10.1016/0140-6736(91)91440-6 · Cited by 353
Hörkkö, S., Miller, E., Dudl, E., Reaven, P., Curtiss, L. K., Zvaifler, N. J., Terkeltaub, R., Pierangeli, S. S., Branch, D. W., Palinski, W., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118854 · Cited by 348
Adjuvant Properties of Aluminum and Calcium Compounds
Gupta, R. K., Rost, B. E., Relyveld, E., & Siber, G. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_8 · Cited by 330
Immunological concepts of vaccine adjuvant activity
Schijns, V. E. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00120-5 · Cited by 330
Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts
Gutteridge, J. M. C., Quinlan, G. J., Clark, I., & Halliwell, B. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90113-4 · Cited by 311
Macrophagic myofasciitis: an emerging entity
Gherardi, R., Coquet, M., Chérin, P., Authier, F.-J., Laforêt, P., Bélec, L., Figarella-Branger, D., Mussini, J.-M., Pellissier, J.-F., & Fardeau, M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02326-5 · Cited by 244
Self-citationUlanova, M., Tarkowski, A., Hahn-Zoric, M., & Hanson, L. Å. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1151-1159.2001 · Cited by 239
Casciola-Rosen, L., Wigley, F., & Rosen, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.71 · Cited by 213
In vivo absorption of aluminium-containing vaccine adjuvants using 26Al
Flarend, R. E., Hem, S. L., White, J. L., Elmore, D., Suckow, M. A., Rudy, A. C., & Dandashli, E. A. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00041-8 · Cited by 199
The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
Storey, & Cappai (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00164.x · Cited by 169
Aluminum Compounds Used as Adjuvants in Vaccines
Shirodkar, S., Hutchinson, R. L., Perry, D. L., White, J. L., & Hem, S. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015994006859 · Cited by 162
Central nervous system disease in patients with macrophagic myofasciitis
Authier, F., Cherin, P., Creange, A., Bonnotte, B., Ferrer, X., Abdelmoumni, A., Ranoux, D., Pelletier, J., Figarella-Branger, D., Granel, B., et al. (2001) · Brain · doi:10.1093/brain/124.5.974 · Cited by 154
Self-citationGulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?
Rook, G. A. W., & Zumla, A. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01164-1 · Cited by 141
Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons
McMahon, B. J., Helminiak, C., Wainwright, R. B., BULKOW, L. R., Trimble, B. A., & Wainwright, K. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90073-k · Cited by 132
Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome.
Konstantinov, K. N., von Mikecz, A. H., Buchwald, D., Jones, J. F., Gerace, L., & Tan, E. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118990 · Cited by 131
Petrovas, C., Vlachoyiannopoulos, P. G., Kordossis, T., & Moutsopoulos, H. Μ. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0324 · Cited by 103
García‐Patos, V., Pujol, R. M., Alomar, A., Cisteró, A., Curell, R., Fernández-Figueras, M. T., & de Moragas, J. M. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.12.1421 · Cited by 93
Histopathological Studies of Reactions in Mice Injected with Aluminum‐Adsorbed Tetanus Toxoid
Goto, N., & Akama, K. (1982) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1982.tb00261.x · Cited by 91
Reactive Oxygen Species Expose Cryptic Epitopes Associated with Autoimmune Goodpasture Syndrome
Kalluri, R., Cantley, L. G., Kerjaschki, D., & Neilson, E. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m904549199 · Cited by 88
Fournié, G. J., Mas, M., Cautain, B., Savignac, M., Subra, J., Pelletier, L., Saoudi, A., Lagrange, D., Calise, M., & Druet, P. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0482 · Cited by 83
(2000) · PubMed · Cited by 75
Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons
Xie, C. X., Mattson, M. P., Lovell, M. A., & Yokel, R. A. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01055-4 · Cited by 74
Inter-subject variability in the metabolism of aluminium following intravenous injection as citrate
Talbot, R. J. E., Newton, D., Priest, N. D., Austin, J. G., & Day, J. (1995) · Human & Experimental Toxicology · doi:10.1177/096032719501400707 · Cited by 63
Hamilton, J. A., Byrne, R. A., & Whitty, G. A. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.2.226 · Cited by 63
Hassan, I. S., Bannister, B. A., Akbar, A. N., Weir, W., & Bofill, M. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4512 · Cited by 58
Miliauskas, J. R., Mukherjee, T. M., & Dixon, B. (1993) · PubMed · Cited by 55
Prooxidant action of aluminum Ion – Stimulation of iron-mediated lipid peroxidation by aluminum
Yoshino, M., Ito, M., Haneda, M., Tsubouchi, R., & Murakami, K. (1999) · BioMetals · doi:10.1023/a:1009238732287 · Cited by 49
Gallium-67 scintigraphy in macrophagic myofasciitis
Cherin, P., Authier, F., Gherardi, R. K., Romero, N. B., Laforêt, P., Eymard, B., Herson, S., Caillat‐Vigneron, N., & DYSIMMUNITAIRES, F. T. G. D. E. D. R. S. L. M. M. A. E. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200007)43:7<1520::aid-anr16>3.0.co;2-q · Cited by 42
Self-citationMuscle granulomas following intramuscular injection
Mrak, R. E. (1982) · Muscle & Nerve · doi:10.1002/mus.880050808 · Cited by 26
Nuclear microprobe: a microanalytical technique in biology.
Moretto, P. (1996) · PubMed · Cited by 19
Postimmunization (Vaccination) Injection-site Reactions
Stringfellow, H. F., & Howat, A. J. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199411000-00015 · Cited by 14
Safety in Growth Hormone Replacement Therapy: A Matter of Varied Responsiveness?
Wilton, P. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063477 · Cited by 11
Cited by
‘ASIA’ – Autoimmune/inflammatory syndrome induced by adjuvants
Shoenfeld, Y., & Agmon-Levin, N. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.07.003 · Cited by 1,010
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide
Krewski, D., Yokel, R. A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew, S., Lindsay, J., Mahfouz, A. M., & Rondeau, V. (2007) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701597766 · Cited by 998
Nanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
Advances in aluminum hydroxide-based adjuvant research and its mechanism
He, P., Zou, Y., & Hu, Z. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2014.1004026 · Cited by 409
Exley, C. (2013) · Environ. Sci.: Processes Impacts · doi:10.1039/c3em00374d · Cited by 382
Metadata
- Authors
- Gherardi, R. K.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09-01
- Volume
- 124
- Issue
- 9
- Pages
- 1821-1831
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2139019351
- Cited by
- 361
- References
- 38
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.